$MLAB

MESA LABORATORIES INC /CO/

No enriched coverage for $MLAB in the last 7 days.

No SEC Form 4 filings for $MLAB in the last 30 days.

Med

Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on June 15, 2026

Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. This dividend will be payable on June 15, 2026, to shareholders who are of record at the close of business on May 29, 2026. The announcement was made on April 3, 2026.

Mesa Laboratories Names New CEO for Next Phase

Mesa Laboratories announced that CEO Gary Owens will step down on April 12, 2026, after leading the company since 2017. Dr. Siddhartha Kadia has been appointed as the new President, CEO, and director, effective April 13, 2026, with a compensation package designed to drive the company's next phase of growth. Spark’s AI Analyst rates MLAB stock as Neutral, citing strong cash generation but unstable net earnings and mixed technical momentum.